Synthesis and biological evaluation of pyranocarbazole derivatives as Anti-tumor agents. 2021

Ke Liu, and Yingda Zang, and Cangjie Shen, and Chuangjun Li, and Jie Ma, and Jingzhi Yang, and Xingyan Sun, and Xinyi Chen, and Nan Wang, and Dongming Zhang
State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.

A series of pyrano[3,2-a]carbazole alkaloids were designed and synthesized as derivatives of Girinimbine. The anticancer activities of these derivatives (3, 4a-j, 5a, 5c, 5f, 5i, 6c, 7a, 7c, 7f, 7i) against 10 cancer cell lines were studied. Among them, compounds 3 and 7i with N-methyl piperazine showed significant anticancer activity against MCF-7 cell lines with the IC50 values of 1.77 and 4.32 μM, respectively. Furthermore, their effects on altering cell morphology, inducing cell cycle arrest and apoptosis in MCF-7 cells were studied in vitro. In addition, the molecular docking study was carried out by using Discovery Studio software to predict the interactions between these derivatives and tubulin. All in all, these consequences reveal that pyranocarbazole derivatives with N-methyl piperazine can be used as potential anticancer lead compounds and provide useful points for the further optimization of pyranocarbazole alkaloids.

UI MeSH Term Description Entries
D011714 Pyrans Pyran
D002227 Carbazoles Benzo-indoles similar to CARBOLINES which are pyrido-indoles. In plants, carbazoles are derived from indole and form some of the INDOLE ALKALOIDS.
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Ke Liu, and Yingda Zang, and Cangjie Shen, and Chuangjun Li, and Jie Ma, and Jingzhi Yang, and Xingyan Sun, and Xinyi Chen, and Nan Wang, and Dongming Zhang
April 2012, Molecules (Basel, Switzerland),
Ke Liu, and Yingda Zang, and Cangjie Shen, and Chuangjun Li, and Jie Ma, and Jingzhi Yang, and Xingyan Sun, and Xinyi Chen, and Nan Wang, and Dongming Zhang
January 2015, Steroids,
Ke Liu, and Yingda Zang, and Cangjie Shen, and Chuangjun Li, and Jie Ma, and Jingzhi Yang, and Xingyan Sun, and Xinyi Chen, and Nan Wang, and Dongming Zhang
August 2009, Bioorganic & medicinal chemistry letters,
Ke Liu, and Yingda Zang, and Cangjie Shen, and Chuangjun Li, and Jie Ma, and Jingzhi Yang, and Xingyan Sun, and Xinyi Chen, and Nan Wang, and Dongming Zhang
August 2018, Molecules (Basel, Switzerland),
Ke Liu, and Yingda Zang, and Cangjie Shen, and Chuangjun Li, and Jie Ma, and Jingzhi Yang, and Xingyan Sun, and Xinyi Chen, and Nan Wang, and Dongming Zhang
December 2022, European journal of medicinal chemistry,
Ke Liu, and Yingda Zang, and Cangjie Shen, and Chuangjun Li, and Jie Ma, and Jingzhi Yang, and Xingyan Sun, and Xinyi Chen, and Nan Wang, and Dongming Zhang
January 2023, Drug design, development and therapy,
Ke Liu, and Yingda Zang, and Cangjie Shen, and Chuangjun Li, and Jie Ma, and Jingzhi Yang, and Xingyan Sun, and Xinyi Chen, and Nan Wang, and Dongming Zhang
April 2021, RSC advances,
Ke Liu, and Yingda Zang, and Cangjie Shen, and Chuangjun Li, and Jie Ma, and Jingzhi Yang, and Xingyan Sun, and Xinyi Chen, and Nan Wang, and Dongming Zhang
September 2014, Fitoterapia,
Ke Liu, and Yingda Zang, and Cangjie Shen, and Chuangjun Li, and Jie Ma, and Jingzhi Yang, and Xingyan Sun, and Xinyi Chen, and Nan Wang, and Dongming Zhang
April 2013, European journal of medicinal chemistry,
Ke Liu, and Yingda Zang, and Cangjie Shen, and Chuangjun Li, and Jie Ma, and Jingzhi Yang, and Xingyan Sun, and Xinyi Chen, and Nan Wang, and Dongming Zhang
January 2012, European journal of medicinal chemistry,
Copied contents to your clipboard!